Suppr超能文献

p300 介导的乙酰化对 p68 和 p72 RNA 解旋酶的多效性作用。

Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.

机构信息

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

J Biol Chem. 2010 Oct 1;285(40):30443-52. doi: 10.1074/jbc.M110.143792. Epub 2010 Jul 27.

Abstract

Here, we demonstrate that p68 (DDX5) and p72 (DDX17), two homologous RNA helicases and transcriptional cofactors, are substrates for the acetyltransferase p300 in vitro and in vivo. Mutation of acetylation sites affected the binding of p68/p72 to histone deacetylases, but not to p300 or estrogen receptor. Acetylation additionally increased the stability of p68 and p72 RNA helicase and stimulated their ability to coactivate the estrogen receptor, thereby potentially contributing to its aberrant activation in breast tumors. Also, acetylation of p72, but not of p68 RNA helicase, enhanced p53-dependent activation of the MDM2 promoter, pointing at another mechanism of how p72 acetylation may facilitate carcinogenesis by boosting the negative p53-MDM2 feedback loop. Furthermore, blocking p72 acetylation caused cell cycle arrest and apoptosis, revealing an essential role for p72 acetylation. In conclusion, our report has identified for the first time that acetylation modulates RNA helicases and provides multiple mechanisms how acetylation of p68 and p72 may affect normal and tumor cells.

摘要

在这里,我们证明了 p68(DDX5)和 p72(DDX17)这两种同源 RNA 解旋酶和转录共因子是乙酰转移酶 p300 的体外和体内的底物。乙酰化位点的突变影响了 p68/p72 与组蛋白去乙酰化酶的结合,但不影响 p300 或雌激素受体。乙酰化还增加了 p68 和 p72 RNA 解旋酶的稳定性,并刺激了它们激活雌激素受体的能力,从而可能导致其在乳腺癌中的异常激活。此外,p72 RNA 解旋酶的乙酰化而不是 p68 的乙酰化增强了 p53 依赖性的 MDM2 启动子的激活,指出了 p72 乙酰化如何通过增强负反馈环 p53-MDM2 促进致癌作用的另一种机制。此外,阻断 p72 乙酰化导致细胞周期停滞和细胞凋亡,揭示了 p72 乙酰化的重要作用。总之,我们的报告首次确定了乙酰化调节 RNA 解旋酶,并提供了 p68 和 p72 乙酰化影响正常和肿瘤细胞的多种机制。

相似文献

1
Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.
J Biol Chem. 2010 Oct 1;285(40):30443-52. doi: 10.1074/jbc.M110.143792. Epub 2010 Jul 27.
3
Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF.
J Cell Biochem. 2007 Aug 1;101(5):1252-65. doi: 10.1002/jcb.21250.
5
8
The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators.
Biochem Soc Trans. 2008 Aug;36(Pt 4):609-12. doi: 10.1042/BST0360609.
10
Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53.
Biochem Biophys Res Commun. 2008 Sep 26;374(3):437-41. doi: 10.1016/j.bbrc.2008.07.038. Epub 2008 Jul 16.

引用本文的文献

1
Anti-tumor activity of CDYL2b in prostate cancer.
Cancer Lett. 2025 Aug 12;632:217987. doi: 10.1016/j.canlet.2025.217987.
2
PAK4 promotes the cytoskeletal organization and meiotic maturation via phosphorylating DDX17 in oocyte.
Cell Commun Signal. 2025 Feb 13;23(1):85. doi: 10.1186/s12964-025-02085-3.
5
Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis.
Front Oncol. 2023 Nov 17;13:1295613. doi: 10.3389/fonc.2023.1295613. eCollection 2023.
6
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
JCI Insight. 2023 Oct 23;8(20):e164990. doi: 10.1172/jci.insight.164990.
7
Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of and .
Front Oncol. 2023 Feb 20;13:1122238. doi: 10.3389/fonc.2023.1122238. eCollection 2023.
8
DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression.
Front Oncol. 2022 Aug 3;12:943032. doi: 10.3389/fonc.2022.943032. eCollection 2022.
9
Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
Int J Clin Exp Pathol. 2021 Jul 15;14(7):795-810. eCollection 2021.
10
The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.
Int J Clin Oncol. 2021 May;26(5):795-825. doi: 10.1007/s10147-021-01892-1. Epub 2021 Mar 3.

本文引用的文献

3
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Cancer Res. 2009 Oct 15;69(20):8102-10. doi: 10.1158/0008-5472.CAN-09-0941. Epub 2009 Sep 29.
5
The genetics of the p53 pathway, apoptosis and cancer therapy.
Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656.
6
Current perspective - trastuzumab.
Eur J Cancer. 2009 Jan;45(1):12-8. doi: 10.1016/j.ejca.2008.10.013. Epub 2008 Nov 29.
8
Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.
J Cell Biochem. 2008 Oct 15;105(3):866-74. doi: 10.1002/jcb.21884.
9
Lysine acetylation: codified crosstalk with other posttranslational modifications.
Mol Cell. 2008 Aug 22;31(4):449-461. doi: 10.1016/j.molcel.2008.07.002.
10
Repression of Smad3 activity by histone demethylase SMCX/JARID1C.
Biochem Biophys Res Commun. 2008 Feb 8;366(2):563-7. doi: 10.1016/j.bbrc.2007.12.013. Epub 2007 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验